16 November 2026
DLA Piper advises Heron Therapeutics on sale of substantially all assets to CorMedix Therapeutics
Advising firms
Deal team
20 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Andrew Gilbert Lead | DLA Piper | Partner | Not stated | Not stated |
| Jeffrey Scharfstein Lead | DLA Piper | Partner | Not stated | Not stated |
| Emilio Ragosa Lead | DLA Piper | Partner | Not stated | Not stated |
| Carina Meleca Lead | DLA Piper | Partner | Not stated | Not stated |
| Gina Lee Lead | DLA Piper | Partner | Not stated | Not stated |
| Lisa Liu | DLA Piper | Associate | Not stated | Not stated |
| Thais Lopez | DLA Piper | Associate | Not stated | Not stated |
| Brian Sunberg | DLA Piper | Associate | Not stated | Not stated |
| Destiny Harrison | DLA Piper | Associate | Not stated | Not stated |
| Lauren Murdza | DLA Piper | Partner | Not stated | Not stated |
| Michelle Lara | DLA Piper | Partner | Not stated | Not stated |
| W. Kurtis Weaver | DLA Piper | Partner | Not stated | Not stated |
| Jeffrey Aronson | DLA Piper | Partner | Not stated | Not stated |
| Georgia Jolink | DLA Piper | Partner | Not stated | Not stated |
| Paolo Morante | DLA Piper | Partner | Not stated | Not stated |
| Richard Marks | DLA Piper | Partner | Not stated | Not stated |
| Jennifer Kashatus | DLA Piper | Partner | Not stated | Not stated |
| Preeya Pinto | DLA Piper | Partner | Not stated | Not stated |
| Christopher Mikson | DLA Piper | Partner | Not stated | Not stated |
| Bryna Shmerling | DLA Piper | Of counsel | Not stated | Not stated |
17 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 145m (US$145 million)
- What the figure measures
- Total transaction value
- Client
- Heron TherapeuticsSell-side
- Counterparties
- CorMedix Therapeutics (Buy-side)